Prostate Cancer - Results from #19060

Dynamic contrast-enhanced MR imaging curve-type analysis: Is it helpful in the differentiation of prostate cancer from healthy peripheral zone? - Abstract March 5, 2015

Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer - Abstract March 5, 2015

Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian Transperineal Biopsy Collaboration experience - Abstract March 5, 2015

Prostate cancer risk estimation tool usage among members of the American Urological Association (AUA): A survey-based study - Abstract March 5, 2015

Comparing nonrigid registration techniques for motion corrected MR prostate diffusion imaging - Abstract March 5, 2015

Novel tools for stepping source brachytherapy treatment planning: Enhanced geometrical optimization and interactive inverse planning - Abstract March 5, 2015

Digital solutions for informed decision making: An academic-community partnership for the development of a prostate cancer decision aid for African American men - Abstract March 5, 2015

Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study - Abstract March 5, 2015

Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer - Abstract March 5, 2015

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): - Abstract March 5, 2015

Progressive computed tomography (CT) appearances preceding malignant spinal cord compression (MSCC) in men with castration-resistant prostate cancer - Abstract March 5, 2015

Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer - Abstract March 5, 2015

Prognostic value of saturated prostate cryoablation for localized prostate cancer - Abstract March 5, 2015

Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: Experience with 1,000 patients - Abstract March 5, 2015

Enhanced recovery pathway for radical prostatectomy: Implementation and evaluation in a universal healthcare system - Abstract March 5, 2015

National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009 - Abstract March 5, 2015

Gleason score at the margin can predict biochemical recurrence after radical prostatectomy, in addition to preoperative PSA and surgical margin status - Abstract March 5, 2015

Opportunistic testing versus organized prostate-specific antigen screening: Outcome after 18 years in the Göteborg Randomized Population-based Prostate Cancer Screening trial - Abstract March 5, 2015

Treatment modalities for Māori and New Zealand European men with localised prostate cancer - Abstract March 5, 2015

The high prevalence of undiagnosed prostate cancer at autopsy: Implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era - Abstract March 5, 2015

Page 954 of 1458